PMC:7652766 / 80518-80770
Annnotations
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T394 | 0-252 | Sentence | denotes | A randomized phase I/II trial studied the infusions of CYNK-001 cells, an allogeneic off-the-shelf cell therapy enriched for CD56+/CD3- NK cells expanded from human placental CD34+ cells in 86 hospitalized patients with moderate COVID-19 disease (283). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2908 | 125-129 | Gene | denotes | CD56 | Gene:4684 |
| 2909 | 175-179 | Gene | denotes | CD34 | Gene:947 |
| 2917 | 159-164 | Species | denotes | human | Tax:9606 |
| 2918 | 206-214 | Species | denotes | patients | Tax:9606 |
| 2921 | 0-1 | Gene | denotes | A | Gene:351 |
| 2922 | 229-237 | Disease | denotes | COVID-19 | MESH:C000657245 |